TMO
Thermo Fisher Scientific Inc.
Healthcare
$449.37
as of May 21, 2026
Sign in to add TMO to your portfolio.
Sign inMarket cap
$167.89B
P/E (TTM)
24.5x
EPS (TTM)
$18.44
Dividend yield
0.39%
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $39.21B | $7.72B | $7.02B | 50.1% | 26.3% | $19.61 |
| 2022 | $44.91B | $6.95B | $6.91B | 42.3% | 19.0% | $17.73 |
| 2023 | $42.86B | $6.00B | $6.93B | 40.1% | 17.4% | $15.53 |
| 2024 | $42.88B | $6.33B | $7.27B | 41.3% | 17.9% | $16.58 |
| 2025 | $44.56B | $6.74B | $6.29B | 37.7% | 18.2% | $17.77 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $450.90 | $449.37 | 2.01M |
| May 20, 2026 | $449.09 | $451.79 | 2.85M |
| May 19, 2026 | $442.00 | $447.81 | 3.42M |
| May 18, 2026 | $438.44 | $442.00 | 1.90M |
| May 15, 2026 | $444.02 | $438.34 | 2.04M |
| May 14, 2026 | $448.21 | $448.21 | 2.10M |
| May 13, 2026 | $455.18 | $446.03 | 2.80M |
| May 12, 2026 | $454.34 | $459.30 | 3.06M |
| May 11, 2026 | $464.86 | $452.60 | 3.95M |
| May 08, 2026 | $473.49 | $465.00 | 3.91M |
| May 07, 2026 | $473.36 | $474.46 | 2.53M |
| May 06, 2026 | $471.16 | $472.95 | 1.86M |
| May 05, 2026 | $464.77 | $466.76 | 2.05M |
| May 04, 2026 | $466.98 | $462.60 | 1.82M |
| May 01, 2026 | $480.00 | $469.21 | 1.43M |
| Apr 30, 2026 | $464.23 | $478.96 | 2.16M |
| Apr 29, 2026 | $467.25 | $466.26 | 1.39M |
| Apr 28, 2026 | $471.99 | $470.22 | 2.24M |
| Apr 27, 2026 | $462.66 | $468.04 | 2.28M |
| Apr 24, 2026 | $469.15 | $469.71 | 2.68M |
| Apr 23, 2026 | $472.65 | $466.70 | 5.73M |
| Apr 22, 2026 | $526.62 | $513.98 | 1.80M |
| Apr 21, 2026 | $529.87 | $524.57 | 2.14M |
| Apr 20, 2026 | $522.83 | $526.02 | 1.44M |
Profitability & balance
- ROE (TTM)
- 13.3%
- Gross margin
- 39.4%
- Operating margin
- 17.8%
- Net margin
- 15.2%
- Debt / equity
- 0.83